Editorial: The therapeutic inhibition of macrophage checkpoints
- PMID: 38736871
- PMCID: PMC11088240
- DOI: 10.3389/fimmu.2024.1418281
Editorial: The therapeutic inhibition of macrophage checkpoints
Keywords: cd47; immune checkpoints; immunotherapy; macrophages; signal regulatory protein alpha.
Conflict of interest statement
AT has patented “Compositions and methods for treating hematologic cancers targeting the SIRPalpha-CD47 interaction” and was previously a shareholder of Trillium Therapeutics Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic The therapeutic inhibition of macrophage checkpoints
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources